Correlation Between Structure Therapeutics and Transcode Therapeutics

Can any of the company-specific risk be diversified away by investing in both Structure Therapeutics and Transcode Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Structure Therapeutics and Transcode Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Structure Therapeutics American and Transcode Therapeutics, you can compare the effects of market volatilities on Structure Therapeutics and Transcode Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Structure Therapeutics with a short position of Transcode Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Structure Therapeutics and Transcode Therapeutics.

Diversification Opportunities for Structure Therapeutics and Transcode Therapeutics

-0.41

Correlation Coefficient

Structure Therapeutics  Transcode Therapeutics

Very good diversification

The 3 months correlation between Structure and Transcode is -0.41. Overlapping area represents the amount of risk that can be diversified away by holding Structure Therapeutics America and Transcode Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Transcode Therapeutics and Structure Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Structure Therapeutics American are associated (or correlated) with Transcode Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Transcode Therapeutics has no effect on the direction of Structure Therapeutics i.e., Structure Therapeutics and Transcode Therapeutics go up and down completely randomly.

Pair Corralation between Structure Therapeutics and Transcode Therapeutics

Given the investment horizon of 90 days Structure Therapeutics American is expected to generate 2.29 times more return on investment than Transcode Therapeutics. However, Structure Therapeutics is 2.29 times more volatile than Transcode Therapeutics. It trades about 0.18 of its potential returns per unit of risk. Transcode Therapeutics is currently generating about -0.01 per unit of risk. If you would invest  2,020  in Structure Therapeutics American on September 15, 2025 and sell it today you would earn a total of  4,686  from holding Structure Therapeutics American or generate 231.98% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	98.46%
Values	Daily Returns

Structure Therapeutics America  vs.  Transcode Therapeutics

Structure Therapeutics

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Structure Therapeutics American are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak fundamental indicators, Structure Therapeutics reported solid returns over the last few months and may actually be approaching a breakup point.

Transcode Therapeutics

Risk-Adjusted Performance

Weakest

Over the last 90 days Transcode Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Transcode Therapeutics is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Structure Therapeutics and Transcode Therapeutics

The main advantage of trading using opposite Structure Therapeutics and Transcode Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Structure Therapeutics position performs unexpectedly, Transcode Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Transcode Therapeutics will offset losses from the drop in Transcode Therapeutics' long position.

The idea behind Structure Therapeutics American and Transcode Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.